| Autor: |
Shuvalov O; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia., Kirdeeva Y; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia., Daks A; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia., Fedorova O; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia., Parfenyev S; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia., Simon HU; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia., Barlev NA; Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia.; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 20000, Kazakhstan. |
| Abstrakt: |
Cancer metabolic reprogramming is a complex process that provides malignant cells with selective advantages to grow and propagate in the hostile environment created by the immune surveillance of the human organism. This process underpins cancer proliferation, invasion, antioxidant defense, and resistance to anticancer immunity and therapeutics. Perhaps not surprisingly, metabolic rewiring is considered to be one of the "Hallmarks of cancer". Notably, this process often comprises various complementary and overlapping pathways. Today, it is well known that highly selective inhibition of only one of the pathways in a tumor cell often leads to a limited response and, subsequently, to the emergence of resistance. Therefore, to increase the overall effectiveness of antitumor drugs, it is advisable to use multitarget agents that can simultaneously suppress several key processes in the tumor cell. This review is focused on a group of plant-derived natural compounds that simultaneously target different pathways of cancer-associated metabolism, including aerobic glycolysis, respiration, glutaminolysis, one-carbon metabolism, de novo lipogenesis, and β-oxidation of fatty acids. We discuss only those compounds that display inhibitory activity against several metabolic pathways as well as a number of important signaling pathways in cancer. Information about their pharmacokinetics in animals and humans is also presented. Taken together, a number of known plant-derived compounds may target multiple metabolic and signaling pathways in various malignancies, something that bears great potential for the further improvement of antineoplastic therapy. |
